Back
Zevra Therapeutics, Inc. Stock Predictions
When an AI Platform Gets Pulled by Too Much Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
39
ZVRA
Zevra Therapeutics, Inc.
Last Price:
$8.60
Seasonality Move:
-4.54%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Phase of AI Is Not About Chat
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.comZevra Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Zevra Therapeutics, Inc. has on average historically fallen by 11.7% based on the past 10 years of stock performance.
-
Zevra Therapeutics, Inc. has fallen lower in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Zevra Therapeutics, Inc. Stock Undervalued?The current Zevra Therapeutics, Inc. [ZVRA] share price is $8.60. The Score for ZVRA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
ZVRA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Zevra Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Zevra Therapeutics, Inc. has on average historically fallen by 11.7% based on the past 10 years of stock performance.
Zevra Therapeutics, Inc. Stock Rating
Sell
39
Zevra Therapeutics, Inc. (ZVRA)
is a Sell
Is Zevra Therapeutics, Inc. overpriced?
-
Zevra Therapeutics, Inc. has fallen lower in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Zevra Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
zevra.com
52-Week Data
52-Week High:
13.16
52-Week Low:
6.19
Prediction Charts
Market Cap:
484.2M
Price in USD:
8.60
Volume:
604.3K
Beta:
1.81
Technical Analysis
SMA50:
8.65
SMA100:
9.19
SMA200:
9.32
52-Wk Change:
9.14%
Stock Predictions
-
Is Zevra Therapeutics, Inc. stock public?Yes, Zevra Therapeutics, Inc. is a publicly traded company.
-
What is the Zevra Therapeutics, Inc. stock quote today?The Zevra Therapeutics, Inc. stock price is 8.60 USD today.
-
How to buy Zevra Therapeutics, Inc. stock online?You can buy Zevra Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-20 | 8.82 | 9.02 | 9.15 | 8.66 |
| Jan-21 | 9.01 | 9.03 | 9.15 | 8.72 |
| Jan-22 | 9.05 | 9.08 | 9.56 | 8.97 |
| Jan-23 | 9.17 | 8.97 | 9.60 | 8.95 |
| Jan-26 | 8.93 | 9.02 | 9.20 | 8.75 |
| Jan-27 | 8.98 | 8.93 | 9.10 | 8.90 |
| Jan-28 | 8.93 | 8.63 | 8.99 | 8.59 |
| Jan-29 | 8.64 | 8.86 | 8.96 | 8.51 |
| Jan-30 | 8.79 | 9.00 | 9.05 | 8.56 |
| Feb-2 | 8.94 | 9.36 | 9.54 | 8.87 |
| Feb-3 | 9.27 | 9.16 | 9.62 | 8.91 |
| Feb-4 | 9.20 | 8.94 | 9.25 | 8.80 |
| Feb-5 | 8.87 | 8.36 | 9.19 | 8.32 |
| Feb-6 | 8.53 | 8.60 | 8.75 | 8.48 |
Zevra Therapeutics, Inc. Earnings
Zevra Therapeutics, Inc. Earnings Report: Per Share Zevra Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Zevra Therapeutics, Inc. Forecast Revenue Growth
Zevra Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Zevra Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.54 per share, and an increase next year of $1.12 per share.
* Zevra Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.